A retrospective study was conducted in 2008 on 681 in Eastern Morocco in order to estimate the incidence of cervical and breast cancer, and to determine the social determinants and risk factors associated with these two types of cancer. Another goal of the study was to give health decision makers evidence of the necessity for early diagnosis and treatment. A questionnaire was used before the clinical gynecological examination and sampling cell for the Pap smear. Any woman with a Pap smear suspect had to do a biopsy at the reference centre. Physicians, obstetricians and midwives in the consultation process did gynecological examination and breast palpation. Patients with a suspicious nodule underwent ultrasound and mammography by radiologists on site. Gynecological samples were carried out systematically to all ever-married women to detect cancer of the cervix. Software Excel and SPSS 17 were used for data processing. Patients with high social status were more susceptible to develop breast cancer whereas women with cervical cancer were poor, belonging to a class with a low marital status of widowed or divorced having been married at an early age. The majority of women were married (81%), poor (80%) and illiterate (66%). Breastfeeding women were less affected by breast cancer than women not breastfeeding. For cervical cancer, the difference was not statistically significant. Women using contraceptives were vulnerable to both breast and cervical cancer. For cervical cancer, over 15% of women with a family history were screened positive. No relationship was found between breast cancer and family history. Taking into account regional particularities, we stress the importance of social determinants and risk factors and show that our results are consistent with those published by other researchers. Breast and cervical cancers constitute a real challenge in Morocco. Their socioeconomic burden can be reduced by early detection and treatment. The delayed diagnosis complicates the task both in terms of survival and cost of treatment. Consequently, Moroccan health authorities are urged to adopt preventive and cost effective strategies
Pilomatrixoma, also known as calcified epithelioma of Malherbe, is the most common tumor of the hair follicle. It is a benign tumor in a young adult. Pilomatrixoma is most commonly located in the head and neck. It is usually misdiagnosed and confused with other skin lesions. The authors report a rare localization of this tumor in the left hand in a 40-year-old patient treated surgically without recurrence after four years of follow-up.
We report on a case of liposarcoma of the spermatic cord treated with radical orchidectomy and wide excision of the tumour without adjuvant treatment. After 16 years of follow up, neither local nor distant recurrences were detected. Spermatic cord liposarcoma is a rare disease. The basic treatment for all patients with spermatic cord liposarcoma is radical orchidectomy with wide local resection and high ligature of the spermatic cord. The role of postoperative irradiation depends on pathologic findings. Local recurrences are rare but because of late events, a long follow-up is mandatory. Keywords: Spermatic cord, Liposarcoma, Prostate cancer ÖZET Spermatik Kord Liposarkomuna Efllik Eden Prostat KanseriSunulan olgu, radikal orfliektomi ve genifl lokal eksizyon ile tedavi edilmifl ve baflka adjuvan tedavi almam›fl spermatik kord yerleflimli liposarkomdur. 16 y›l boyunca ne lokal ne de uzak metastaz saptanmad›. Spermatik kord liposarkomu nadir görülen bir hastal›kt›r. Spermatik kord liposarkomal› tan›l› bütün hastalarda ana tedavi radikal orfliektomi ve genifl lokal eksizyon ve spermatik kordun yük-sek ba¤lanmas›d›r (high ligation). Postoperatif radyoterapinin rolü patolojik bulgulara ba¤l›d›r. Lokal nüks nadirdir olup geç olaylar için uzun süre takip gerekmektedir.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.